COVID-19 in Southeast Asia: current status and perspectives

Bioengineered. 2022 Feb;13(2):3797-3809. doi: 10.1080/21655979.2022.2031417.

Abstract

Coronavirus Disease-2019 (COVID-19) has spread globally with catastrophic damages to the public health, social and economy since the beginning of the outbreak. In 2020, Southeast Asia proved that it could prevent the worst effects of a pandemic through the closure of activities and borders and movement restriction, as well as social distancing. Nevertheless, with the occurrence of the common variants of concern (VOCs), especially Alpha (B.1.1.7), Beta (B.1.351), Delta (B.1.617.2), Southeast Asia is facing a significant increase in the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infections. Now, the area also has the threats of the spreading out of the dangerous variant - Omicron (B.1.1.529) from other close countries or regions. COVID-19 countermeasures such as closures and social distancing seem to be insufficient. Moreover, Southeast Asia is being held back by a shortage of vaccines and other medical resources. This work focuses on describing the COVID-19 situation, the virus variants, and the coverage of COVID-19 vaccination in the area. We also provide perspectives on the COVID-19 vaccine distribution, protecting the economic capitals, developing the green zone, and the importance of finding more vaccine supplies in Southeast Asia.

Keywords: COVID-19; SARS-CoV-2; Southeast Asia; omicron variant; perspectives.

Publication types

  • Review

MeSH terms

  • Asia, Southeastern
  • COVID-19 Vaccines / administration & dosage
  • COVID-19 Vaccines / therapeutic use
  • COVID-19* / epidemiology
  • COVID-19* / mortality
  • COVID-19* / prevention & control
  • COVID-19* / virology
  • Humans
  • SARS-CoV-2*
  • Vaccination / statistics & numerical data

Substances

  • COVID-19 Vaccines

Supplementary concepts

  • SARS-CoV-2 variants

Grants and funding

The author(s) reported there is no funding associated with the work featured in this article.